Türelmedet kérjük, amíg betöltjük a grafikon adatokat
AstraZeneca PLC közösség
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 29 881,31 Ft, with a 24-hour trading volume of 571,71M Ft. The asset's market cap is 92,64T Ft, after moving 0.26% in the last day.
Tokenized AstraZeneca PLC is trading at 29 998,66 Ft, with a tokenized market cap of 224,98M Ft and a 24-hour trading volume of 23,54M Ft. The tokenized asset has moved -0.76% in the past 24 hours.